HEADER ISOMERASE/ISOMERASE INHIBITOR 08-JUL-14 4TYO TITLE PPIASE IN COMPLEX WITH A NON-PHOSPHATE SMALL MOLECULE INHIBITOR. COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: PPIASE DOMAIN, UNP RESIDUES 45-163; COMPND 5 SYNONYM: PEPTIDYL-PROLYL CIS-TRANS ISOMERASE PIN1,PPIASE PIN1, COMPND 6 ROTAMASE PIN1; COMPND 7 EC: 5.2.1.8; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PIN1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS SBDD, PPIASE, CELL CYCLE, ISOMERASE, SMALL MOLECULE, NUCLEUS, KEYWDS 2 PHOSPHOPROTEIN, ROTAMASE, PEPTIDYL-PROLYL CIS-TRANS ISOMERASE, KEYWDS 3 ISOMERASE-ISOMERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.E.GREASLEY,R.A.FERRE REVDAT 4 27-DEC-23 4TYO 1 REMARK REVDAT 3 22-NOV-17 4TYO 1 SOURCE JRNL REMARK REVDAT 2 01-OCT-14 4TYO 1 JRNL REVDAT 1 20-AUG-14 4TYO 0 JRNL AUTH C.GUO,X.HOU,L.DONG,J.MARAKOVITS,S.GREASLEY,E.DAGOSTINO, JRNL AUTH 2 R.FERRE,M.CATHERINE JOHNSON,P.S.HUMPHRIES,H.LI,G.D.PADERES, JRNL AUTH 3 J.PIRAINO,E.KRAYNOV,B.W.MURRAY JRNL TITL STRUCTURE-BASED DESIGN OF NOVEL HUMAN PIN1 INHIBITORS (III): JRNL TITL 2 OPTIMIZING AFFINITY BEYOND THE PHOSPHATE RECOGNITION POCKET. JRNL REF BIOORG.MED.CHEM.LETT. V. 24 4187 2014 JRNL REFN ESSN 1464-3405 JRNL PMID 25091930 JRNL DOI 10.1016/J.BMCL.2014.07.044 REMARK 2 REMARK 2 RESOLUTION. 1.75 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 18.26 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 21137 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.188 REMARK 3 R VALUE (WORKING SET) : 0.187 REMARK 3 FREE R VALUE : 0.211 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1079 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 11 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.75 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.82 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.11 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2504 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2393 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2365 REMARK 3 BIN R VALUE (WORKING SET) : 0.2376 REMARK 3 BIN FREE R VALUE : 0.2672 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.55 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 139 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1778 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 68 REMARK 3 SOLVENT ATOMS : 161 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.79 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.65 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.06600 REMARK 3 B22 (A**2) : -1.10880 REMARK 3 B33 (A**2) : 2.17490 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 3.49760 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.134 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.117 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.131 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.115 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.948 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 1935 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 2628 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 692 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 53 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 360 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 1935 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 241 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2487 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.05 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 4.10 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 14.87 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4TYO COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 14-JUL-14. REMARK 100 THE DEPOSITION ID IS D_1000202414. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-APR-02 REMARK 200 TEMPERATURE (KELVIN) : 193.0 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-D REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : OSMIC REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21138 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 200 DATA REDUNDANCY : 3.750 REMARK 200 R MERGE (I) : 0.06300 REMARK 200 R SYM (I) : 0.06300 REMARK 200 FOR THE DATA SET : 32.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.81 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.80 REMARK 200 R MERGE FOR SHELL (I) : 0.05000 REMARK 200 R SYM FOR SHELL (I) : 0.50100 REMARK 200 FOR SHELL : 2.710 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.80 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.98 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 10MM DTT, 100MM HEPES, 0.1% (V/V) NP REMARK 280 -40, 1.6M NACITRATE. COMPOUND IN 5%DMSO SOAKED IN TO APO REMARK 280 CRYSTALS @ 250UM., PH 7.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 286K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 58.77950 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 18.26250 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 58.77950 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 18.26250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL UNIT IS THE SAME AS ASYM. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 41 REMARK 465 SER A 42 REMARK 465 HIS A 43 REMARK 465 MET A 44 REMARK 465 GLY A 45 REMARK 465 LYS A 46 REMARK 465 ASN A 47 REMARK 465 GLY A 48 REMARK 465 GLN A 49 REMARK 465 GLY A 50 REMARK 465 GLY B 41 REMARK 465 SER B 42 REMARK 465 HIS B 43 REMARK 465 MET B 44 REMARK 465 GLY B 45 REMARK 465 LYS B 46 REMARK 465 ASN B 47 REMARK 465 GLY B 48 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 69 NE CZ NH1 NH2 REMARK 470 LYS A 117 CD CE NZ REMARK 470 GLN B 94 CG CD OE1 NE2 REMARK 470 LYS B 95 CD CE NZ REMARK 470 LYS B 117 CD CE NZ REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 39X A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 39X B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue GOL B 202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3I6C RELATED DB: PDB REMARK 900 SAME PROTEIN CONSTRUCT WITH SMALL MOLECULE ANALOG INHIBITORS BOUND. REMARK 900 RELATED ID: 3JYJ RELATED DB: PDB REMARK 900 RELATED ID: 3IKG RELATED DB: PDB REMARK 900 RELATED ID: 3IK8 RELATED DB: PDB REMARK 900 RELATED ID: 3IKD RELATED DB: PDB DBREF 4TYO A 45 163 UNP Q13526 PIN1_HUMAN 45 163 DBREF 4TYO B 45 163 UNP Q13526 PIN1_HUMAN 45 163 SEQADV 4TYO GLY A 41 UNP Q13526 EXPRESSION TAG SEQADV 4TYO SER A 42 UNP Q13526 EXPRESSION TAG SEQADV 4TYO HIS A 43 UNP Q13526 EXPRESSION TAG SEQADV 4TYO MET A 44 UNP Q13526 EXPRESSION TAG SEQADV 4TYO GLN A 77 UNP Q13526 LYS 77 ENGINEERED MUTATION SEQADV 4TYO GLN A 82 UNP Q13526 LYS 82 ENGINEERED MUTATION SEQADV 4TYO GLY B 41 UNP Q13526 EXPRESSION TAG SEQADV 4TYO SER B 42 UNP Q13526 EXPRESSION TAG SEQADV 4TYO HIS B 43 UNP Q13526 EXPRESSION TAG SEQADV 4TYO MET B 44 UNP Q13526 EXPRESSION TAG SEQADV 4TYO GLN B 77 UNP Q13526 LYS 77 ENGINEERED MUTATION SEQADV 4TYO GLN B 82 UNP Q13526 LYS 82 ENGINEERED MUTATION SEQRES 1 A 123 GLY SER HIS MET GLY LYS ASN GLY GLN GLY GLU PRO ALA SEQRES 2 A 123 ARG VAL ARG CYS SER HIS LEU LEU VAL LYS HIS SER GLN SEQRES 3 A 123 SER ARG ARG PRO SER SER TRP ARG GLN GLU GLN ILE THR SEQRES 4 A 123 ARG THR GLN GLU GLU ALA LEU GLU LEU ILE ASN GLY TYR SEQRES 5 A 123 ILE GLN LYS ILE LYS SER GLY GLU GLU ASP PHE GLU SER SEQRES 6 A 123 LEU ALA SER GLN PHE SER ASP CYS SER SER ALA LYS ALA SEQRES 7 A 123 ARG GLY ASP LEU GLY ALA PHE SER ARG GLY GLN MET GLN SEQRES 8 A 123 LYS PRO PHE GLU ASP ALA SER PHE ALA LEU ARG THR GLY SEQRES 9 A 123 GLU MET SER GLY PRO VAL PHE THR ASP SER GLY ILE HIS SEQRES 10 A 123 ILE ILE LEU ARG THR GLU SEQRES 1 B 123 GLY SER HIS MET GLY LYS ASN GLY GLN GLY GLU PRO ALA SEQRES 2 B 123 ARG VAL ARG CYS SER HIS LEU LEU VAL LYS HIS SER GLN SEQRES 3 B 123 SER ARG ARG PRO SER SER TRP ARG GLN GLU GLN ILE THR SEQRES 4 B 123 ARG THR GLN GLU GLU ALA LEU GLU LEU ILE ASN GLY TYR SEQRES 5 B 123 ILE GLN LYS ILE LYS SER GLY GLU GLU ASP PHE GLU SER SEQRES 6 B 123 LEU ALA SER GLN PHE SER ASP CYS SER SER ALA LYS ALA SEQRES 7 B 123 ARG GLY ASP LEU GLY ALA PHE SER ARG GLY GLN MET GLN SEQRES 8 B 123 LYS PRO PHE GLU ASP ALA SER PHE ALA LEU ARG THR GLY SEQRES 9 B 123 GLU MET SER GLY PRO VAL PHE THR ASP SER GLY ILE HIS SEQRES 10 B 123 ILE ILE LEU ARG THR GLU HET 39X A 201 43 HET GOL A 202 6 HET 39X B 201 43 HET GOL B 202 6 HETNAM 39X 3-(6-FLUORO-1H-BENZIMIDAZOL-2-YL)-N-(NAPHTHALEN-2- HETNAM 2 39X YLCARBONYL)-D-ALANINE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 39X 2(C21 H16 F N3 O3) FORMUL 4 GOL 2(C3 H8 O3) FORMUL 7 HOH *161(H2 O) HELIX 1 AA1 THR A 81 GLY A 99 1 19 HELIX 2 AA2 ASP A 102 SER A 111 1 10 HELIX 3 AA3 CYS A 113 ARG A 119 5 7 HELIX 4 AA4 GLN A 131 LEU A 141 1 11 HELIX 5 AA5 THR B 81 SER B 98 1 18 HELIX 6 AA6 ASP B 102 SER B 111 1 10 HELIX 7 AA7 CYS B 113 ARG B 119 5 7 HELIX 8 AA8 GLN B 131 ALA B 140 1 10 SHEET 1 AA1 4 ASP A 121 SER A 126 0 SHEET 2 AA1 4 ARG A 54 VAL A 62 -1 N CYS A 57 O LEU A 122 SHEET 3 AA1 4 GLY A 155 GLU A 163 -1 O ILE A 156 N VAL A 62 SHEET 4 AA1 4 VAL A 150 THR A 152 -1 N VAL A 150 O HIS A 157 SHEET 1 AA2 4 ASP B 121 PHE B 125 0 SHEET 2 AA2 4 VAL B 55 VAL B 62 -1 N VAL B 55 O PHE B 125 SHEET 3 AA2 4 ILE B 156 GLU B 163 -1 O LEU B 160 N SER B 58 SHEET 4 AA2 4 VAL B 150 PHE B 151 -1 N VAL B 150 O HIS B 157 SITE 1 AC1 12 HIS A 59 LEU A 61 LYS A 63 CYS A 113 SITE 2 AC1 12 SER A 114 SER A 115 LEU A 122 GLN A 131 SITE 3 AC1 12 PHE A 134 SER A 154 HIS A 157 HOH A 312 SITE 1 AC2 7 THR A 79 GLU A 84 VAL A 150 PHE A 151 SITE 2 AC2 7 HOH A 303 HOH A 314 HOH A 375 SITE 1 AC3 16 HIS B 59 LEU B 61 LYS B 63 ARG B 68 SITE 2 AC3 16 ARG B 69 CYS B 113 SER B 114 SER B 115 SITE 3 AC3 16 LEU B 122 GLN B 131 PHE B 134 SER B 154 SITE 4 AC3 16 GOL B 202 HOH B 307 HOH B 318 HOH B 341 SITE 1 AC4 7 ARG B 68 GLN B 129 GLN B 131 39X B 201 SITE 2 AC4 7 HOH B 303 HOH B 307 HOH B 309 CRYST1 117.559 36.525 51.251 90.00 100.82 90.00 C 1 2 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008506 0.000000 0.001626 0.00000 SCALE2 0.000000 0.027379 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019865 0.00000